3Sixty Biomedicine participated at the The South African Pharmaceutical Exhibition (SAPHEX), the only dedicated pharmaceutical manufacturing event in South Africa and SADC. We proudly launched Flu-Artem, our latest pharmaceutical innovation that offers natural, rapid, and effective relief from colds, fever, flu, and cough. The unique blend comprises of Artemisia Afra, Sutherlandia Frutescens, Cannabidiol (CBD) and Zinc enabling this formulation to provide combination therapy that does not only treat symptoms but also antiviral properties to fight against different strains of the influenza virus. The event was a tremendous success, allowing us to introduce Flu-Artem to key industry leaders and medical practitioners while reinforcing our commitment to innovative, science-backed healthcare solutions.
Beyond showcasing our product, we built a strong network with pharmaceutical companies, equipment manufacturers, packaging specialists, and healthcare professionals. These interactions have opened doors to strategic collaborations and industry partnerships that will help drive the future of 3Sixty Biomedicine.Engagements with fellow exhibitors and trade visitors revealed great potential for new partnerships, reinforcing our position in the market. We are excited about the road ahead and look forward to SAPHEX 2026, where we will reach new frontiers, expand our footprint, and unveil new cutting-edge products that continue to redefine healthcare.
